Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-08-06

Clinical Trial Update: Effect of Clonazepam on Cannabis Withdrawal and Relapse in Treatment-seeking Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial examining whether clonazepam affects cannabis withdrawal symptoms and relapse in treatment-seeking individuals with cannabis use disorder…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clonazepam (Clonazepam)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Cannabis Use Disorder | Phase 2 | Status: COMPLETED | Results posted: 2021-08-06